Highlights
- Survival rates are low and treatments for the disease haven't improved in almost 40 years.
- A new study found a new diagnostic tool. It targets patients with a specific genetic indicator.
- Doctors put forward a proposal before the health department to get annual scans for young people with the genetic marker covered by Medicare.
Listen to the audio